We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+4.12%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$2.02B
AUM Growth
+$1.3B
Cap. Flow
+$1.27B
Cap. Flow %
62.75%
Top 10 Hldgs %
16.65%
Holding
2,553
New
2,161
Increased
164
Reduced
123
Closed
87

Sector Composition

Rank Sector Weight
1 Financials 6.93%
2 Consumer Discretionary 6.9%
3 Healthcare 6.22%
4 Industrials 4.3%
5 Technology 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMAT
2351
DELISTED
Meta Materials Inc. Common Stock
MMAT
$20K ﹤0.01%
+80
New +$20.9K
SRUNW
2352
DELISTED
Silver Run Acquisition Corporation II
SRUNW
$20K ﹤0.01%
+13,475
New +$22.3K
CANF
2353
Can-Fite BioPharma American Depositary Shares
CANF
$6.88M
$19K ﹤0.01%
+4
New +$20.6K
KPRX icon
2354
Kiora Pharmaceuticals
KPRX
$11.4M
$19K ﹤0.01%
+3
New +$19.1K
PWCM
2355
PowerCompute, Inc. Common Stock
PWCM
$1.44M
$19K ﹤0.01%
+1
New +$23.5K
PMTS icon
2356
CPI Card Group
PMTS
$330M
$19K ﹤0.01%
+3,183
New +$27.6K
FABC
2357
Fabric.AI Inc
FABC
$17.5M
$18K ﹤0.01%
+1
New +$20K
CNVS icon
2358
Cineverse
CNVS
$66M
$18K ﹤0.01%
+610
New +$18.5K
QRHC icon
2359
Quest Resource Holding
QRHC
$31.2M
$18K ﹤0.01%
+15,699
New +$24.9K
RCG
2360
RENN Fund
RCG
$20.3M
$18K ﹤0.01%
+12,638
New +$17K
AVGR
2361
DELISTED
Avinger, Inc. Common Stock
AVGR
0
EMX
2362
DELISTED
EMX Royalty
EMX
$17K ﹤0.01%
+20,503
New +$19.3K
HEPA
2363
DELISTED
Hepion Pharmaceuticals
HEPA
0
HHS icon
2364
Harte-Hanks
HHS
$18.5M
$17K ﹤0.01%
+1,583
New +$14.6K
NEON icon
2365
Neonode
NEON
$16.3M
$17K ﹤0.01%
+1,359
New +$15.6K
XMAX
2366
XMAX Inc
XMAX
$585M
$17K ﹤0.01%
+410
New +$14.3K
PLX icon
2367
Protalix BioTherapeutics
PLX
$200M
$17K ﹤0.01%
+2,946
New +$18.9K
SINT icon
2368
SiNtx Technologies
SINT
$10.8M
0
URG
2369
Ur-Energy
URG
$564M
$17K ﹤0.01%
+28,698
New +$17.4K
IDSA
2370
DELISTED
Industrial Services of America
IDSA
$17K ﹤0.01%
+10,409
New +$17.4K
CBK
2371
DELISTED
Christopher & Banks Corporation
CBK
$17K ﹤0.01%
+12,362
New +$17.1K
BAC.WS.B
2372
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$17K ﹤0.01%
+21,722
New +$15.9K
AIXC
2373
AIxCrypto Holdings Inc
AIXC
$16M
0
HURA
2374
TuHURA Biosciences
HURA
$137M
$16K ﹤0.01%
+1
New +$27.4K
OCRX
2375
DELISTED
Ocera Therapeutics, Inc.
OCRX
$16K ﹤0.01%
+14,281
New +$15.3K

Similar funds

Virtu Financial's Q3 2017 Portfolio in Review

As of Q3 2017, Virtu Financial held 2,553 positions worth $2.02B, up 180% from $721M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Virtu Financial deployed $1.27B of net new capital in Q3 2017, opening 2,161 new positions and adding to 164 existing holdings. Its largest new stake was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.

By sector, the portfolio is most concentrated in Financials at 6.9% of assets, up from 5.8% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $24.8M trimmed.

  • Virtu Financial's largest Q3 2017 buy was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
  • Virtu Financial added most to VanEck Gold Miners ETF in Q3 2017, an estimated $40.3M increase.
  • Virtu Financial's biggest Q3 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $24.8M.
  • Virtu Financial fully exited Oneok Partners LP in Q3 2017, selling an estimated $15.5M.
  • Virtu Financial's ten largest holdings make up 17% of its $2.02B portfolio in Q3 2017.
  • Virtu Financial opened 2,161 new positions and closed 87 in Q3 2017.
  • Virtu Financial's portfolio value rose 180% quarter-over-quarter to $2.02B.

Based on Virtu Financial's 13F filing for Q3 2017, filed 15 Nov 2017.